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Les	discours	publics	et	privés	façonnent	la	manière	dont	les	
femmes	font	l’expérience	du	cancer	du	sein	y	compris	leurs	
façons	d’appréhender	les	pensées	négatives	et	de	comprendre	
la	maladie.	Le	 discours	 biomédical	 dominant	 présente	 les	
sentiments	dépressifs	comme	une	maladie	grave	qui	a	besoin	
d’être	traitée	médicalement.	A	l’inverse,	le	discours	“existentiel”	
reconnaît	les	pensées	négatives	comme	un	processus	normal		et	
les	considère	même	nécessaires	à	la	traversée	de	l’épreuve	du	
cancer	et	au	développement	personnel.	La	médicalisation	de	la	
douleur	et	la	prominence	de	la	pensée	positive	comme	norme	
sociale	peuvent	ôter	du	pouvoir	aux	femmes	et	prévenir	la	
planification	d’interventions	cohérentes	au	niveau	des	sphères	
sociale,	culturelle	et	communautaire.
“I	think	you	are	depressed.	It’s	understandable	as	50	percent	
of	women	with	breast	cancer	may	become	depressed.” Many 
Australian women who have breast cancer may be given 
this diagnosis when consulting their general practitioner 
or a psychiatrist. In the dominant expert biomedical and 
psychological discourses, sadness and depressive feelings 
have been conceptualised as a mental illness that should 
be diagnosed early and treated. 
Everybody would agree that great attention needs to be 
paid to the emotional well-being of women with breast 
cancer. However, there are different and conflicting dis-
courses on how to interpret and deal with the emotional 
experiences of living with breast cancer. 
The biomedical framework views illness mainly as a 
biological disease that needs to be identified and treated. 
Interpreting emotional experiences as mental illness is a 
relatively recent phenomenon. In their book, The	Loss	of	
Sadness:	How	Psychiatry	Transformed	Normal	Sorrow	into	
Depressive	Disorder, Allan Horwitz and Jerome Wakefield 
argue that, with the exception of bereavement,	the Diag-
nostic and Statistical Manual of Mental Disorders (dsm) 
recognised no contextual events that might qualify the 
depressive syndrome as a normal response to serious life 
events. Moreover, the growing biomedical literature focus-
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ing on the links between depression, disease progression and 
cancer recurrence, reinforces the notion that depression is 
fundamentally biological (Spiegel and Giese-Davis; Clarke 
and Gawley). Cancer has been conceptualised as a factor 
increasing the risk of clinical depression, with depression 
in turn leading to poorer cancer outcomes. A patient 
information document published by the u.s. National 
Institute of Mental Health describes depression in people 
with cancer as the result of “abnormal functioning of the 
brain” and warns that people may “misinterpret depression’s 
warning signs, mistaking them for inevitable accompani-
ments to cancer” (National Institute of Mental Health). 
In Australia, the psychosocial clinical practice guidelines 
for women with breast cancer published by the National 
Health and Medical Research Council recognises a degree 
of anxiety and depression as normal but emphasizes that 
a large proportion of women with cancer will develop a 
depressive disorder that can interfere with their sleep, diet, 
relationships, and ability to work and that ultimately can 
compromise the success of cancer treatment (National 
Health and Medical Research Council; The Health Re-
port). The Beyondblue fact sheet on “Depression and 
Breast Cancer” states that “depression is more than just 
a low mood, it is a serious illness” and that “up to 50 per 
cent of women with early breast cancer may experience 
depression and/or anxiety in the year after diagnosis.” 
Identifying and treating depression is a major target of 
the Australian mental health policy (Commonwealth De-
partment of Health and Aged Care). Health professionals 
are urged to take action and to identify and treat people 
with cancer who are at risk of depression. Treatment of 
depression increasingly involves the use of pharmacological 
treatment with antidepressant drugs. Biomedical explana-
tions of depression are fully supported by pharmaceutical 
companies through the promotion of antidepressant drugs 
to health professionals and consumers. Prescriptions for 
antidepressants in Australia increased almost fivefold 
between 1990 and 2002 (Mant et al.). In 2006, govern-
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ment expenditure on antidepressants was more than 476 
million Australian dollars (Australian Government and 
Department of Health and Ageing). 
In parallel with the biomedical discourse on depres-
sion, there is an abundant psycho-oncology literature on 
coping with cancer which claims that positive thinking 
is related to a better health status and better chances of 
recovery (Wilkinson; McGrath, Jordens, Montgomery 
and Kerrige), and may boost the immune system to fight 
cancer (Ehrenreich 2009). In the breast cancer culture, 
cheerfulness has become mandatory (Ehrenreich 2001). 
“Positive” narratives of patients are chosen over “negative” 
experiences to inform patients (Swift and Dieppe). 
Other discourses are being used to describe the feelings 
experienced by people living with cancer. In his work on 
the illness narratives of people living with cancer, Arthur 
Frank argues that illness such as cancer is not a disease 
but an essential part of the human experience which needs 
to be lived fully to become meaningful (1991, 1995, 
2004). He says that “we fail to console ourselves with the 
recognition that illness may be necessary to realize all we 
can become as humans” (Frank 2004: 9). He wants to 
emphasize mourning as an affirmation rather than a state 
of mind which should be “treated” quickly and stated that 
“to adjust too rapidly is to treat the loss as simply as an 
incident from which one can bounce back, it devalues 
whom or what has been lost” and considers that even 
fairly deep depression must be accepted as the experience 
of illness (Frank 2002: 40). In Australia Miles Little et 
al. stressed that insights into the nature of the subjective 
experiences of people with cancer could be gained from 
the existentialist philosophers and from the history of 
attitudes to death. Catherine McGrath argues that posi-
tive thinking may have adverse consequences as it could 
lead to a sense of failure and guilt if things go not well 
(McGrath et al.). In the United States, Barbara Ehrenreich 
demonstrated that there was no valid evidence linking 
positive thinking and cancer recovery. She wondered if 
the repression of understandable feelings of anger and fear 
was itself harmful and “weigh on a cancer patient like a 
second disease” (2009: 43). 
There is a sharp contrast between the biomedical 
discourse on the psychological effects of breast cancer 
and the “existential” discourse that would acknowledge 
negative feelings as a “normal” and even needed process 
in the cancer journey. The limitations of the biomedical 
now positioned as experts on people’s subjective experi-
ences who reduce existential questions about the meaning 
of life and illness to technical questions about the most 
effective ways of coping or managing one’s emotional life 
and malfunction (Rose). 
Public and private discourses shape the manners in which 
women experience breast cancer, including their strategies 
for coping with negative feelings and making sense of breast 
cancer illness (Stoppard). A study of the media portrayal of 
depression in high circulating magazines in Canada and the 
u.s. from 1980 to 2005 showed a trend over time towards 
a reductionistic and bio-medicalized notion of depression 
(Clarke and Gawley). In their analysis of print media articles 
on depression in Australia, Rob Rowe et al. showed how 
three key discourses—the biomedical, the psycho-social 
and the administrative/managerial—worked together “to 
produce unhappiness as individualised pathology in need 
of management through biological, psychological or social 
structural controls” (680). Discourses influence the cancer 
patients’ experiences, with cancer patients knowing they 
must tell everyone they are “thinking positive” even if they 
do not feel that way and are not sure what “thinking posi-
tive” means (Wilkinson and Kitzinger). With the “expert” 
advice of health professionals, women are often guided to 
think about their emotional distress in pharmacological and 
psychotherapeutic terms. Patients presenting at medical 
surgeries know that “there is an illness called depression, 
that it seems widespread, and that doctors are there to treat 
it” (Shaw and Kauppinen 131). In 1994, in her famous 
book Patient	No	More:	The	Politics	of	Breast	Cancer, Sharon 
Batt hoped that the increasing participation of women 
with breast cancer in the public sphere would mean that 
their private grief would be acknowledged. She wrote 
“Can a woman truly confront her mortality when her 
lipstick is just right?”(312). Fifteen years later, women are 
framework were first shown by Ivan Illich, 50 years ago 
(1976). His argument is in some ways simple. Death, 
pain, and sickness are part of being human. Irvin Yalom 
argues that confronting death need not result in despair 
that strips away all purpose in life and that it can be an 
awakening experience to a fuller life. All cultures have de-
veloped means to help people cope with all three. Modern 
medicine has unfortunately destroyed these cultural and 
individual capacities, launching instead a biological ap-
proach to defeat death, pain, and sickness. More recently, 
Nikolas Rose argues that doctors and psychotherapists are 
Women are encouraged to express their feelings, but only in a certain 
way: cheerfulness is required and dissent a kind of treason. 
Confronting mortality and painful feelings is not on the agenda even 
if empathy for women with breast cancer has become the norm.
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encouraged to express their feelings, but only in a certain 
way: cheerfulness is required and dissent a kind of treason 
(Ehrenreich 2009). Confronting mortality and painful 
feelings is not on the agenda even if empathy for women 
with breast cancer has become the norm.
Discourses are used in a dialectic way. Women with 
breast cancer may find the medicalization of breast 
cancer to be problematic, but may also be reluctant to 
leave the realm of acute care (Thomas-MacLean). The 
medicalization of their feelings may allow them to gain 
moral sympathy and recognition (Shaw). Investigation 
of cultural models of illness and recovery in breast cancer 
support groups showed evidence of a shared model of 
breast cancer and recovery, but also that certain aspects of 
this model, in particular the importance of maintaining 
a positive attitude and “fighting spirit” were contested 
among members (Coreil, Wilke and Pintado). In a dis-
course analysis of breast cancer self-help groups, Linda 
Bayers showed that survivors faced a major challenge to 
cope with dominant discourses and to affirm themselves 
as authoritative and legitimate “knowers.” The current 
proliferation of personal accounts of grief may represent 
an attempt by patients to recover their voice in the face 
of the medicalization of grief (Walter).
“There is no cure for being alive,” says one of the 
heroes of Salley Vickers’ last novel (20). This is not to 
say that emotional feelings of women living with breast 
cancer should not be properly acknowledged. However, 
it can be argued that the medicalization of human suf-
fering and the promotion of positive thinking as the 
moral normality may disempower women and ignore 
the individual personal growth through the facing of 
life challenges. A focus on individual treatments may 
impair the planning of coherent interventions that take 
into account the broader social, cultural and community 
context. We need to switch the current paradigm from 
representing depressive feelings mainly as a medical ill-
ness to a broader existential understanding of sadness and 
unhappiness in the face of life events in our communities. 
Barbara Ehrenreich (2009) relates the positive thinking 
dogma in the breast cancer world to the prominent cult 
of positive thinking in the United States. She argues 
that the American infatuation with positive thinking 
had not made American people happier but that the 
refusal to consider negative outcomes obscures judgment 
and may have contributed to major failures such as the 
recent economic disaster. She advises to confront prob-
lems openly and defends a vigilant realism and “critical 
thinking” rather than “positive thinking” as the best ways 
forward. Questioning social norms on how women should 
experience breast cancer and fighting the medicalization 
of normal human emotions remain ongoing challenges 
for women living with breast cancer.
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 ILONA MARTONFI
Red Taffeta
The dress I didn’t wear to your wedding,
a red taffeta frock
the cranberry red I didn’t buy:
it was not practical.
My sister would know how to dress: 
silk taffeta strapless gown,
posing beside her husband.
She knows how to be feminine:
she always got the boyfriends,
she knows.
I was molested by my fourth grade teacher.
I would know how to be a woman
at nine, at ten.
A girl in a black and white school photo:
I would be beautiful,
I know
I would not have this secret:
I want to be my sister.
Silk taffeta strapless gown,
posing beside her husband.
Erna’s surgery scars,
cancer-free,
fifteen years on.
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